GO:0060587 regulation of lipoprotein lipid oxidation

Lipoprotein lipid oxidation is the modification of a lipoprotein particle by oxidation of its lipid components, a process that converts native lipoproteins into pro-inflammatory and pro-atherogenic species. The Gene Ontology term GO:0060587, regulation of lipoprotein lipid oxidation, encompasses any process that modulates the rate, frequency, or extent of this oxidative modification. This regulatory node is critical because oxidized lipoproteins, particularly oxidized low-density lipoprotein (ox-LDL), are not merely biomarkers but active drivers of endothelial dysfunction, macrophage foam cell formation, and atherosclerotic plaque progression [6,7]. Understanding how cells and tissues control lipoprotein oxidation is therefore central to cardiovascular biology and to the development of antioxidant and lipid-lowering therapeutics. At the molecular level, lipoprotein lipid oxidation is governed by a balance between pro-oxidant free radicals and enzymes, and protective antioxidant systems. Nitric oxide (NO) serves as a direct regulator of free radical- and enzyme-mediated lipid and lipoprotein oxidation, and its bioavailability is modulated by estradiol and endothelial nitric oxide synthase (eNOS) [2,5]. Redox regulation within lipid rafts of macrophages further controls ox-LDL-mediated foam cell formation, highlighting the cell-type-specific nature of this regulation. In parallel, systemic lipid and lipoprotein metabolism is regulated by transcription factors such as PPARs and Krüppel-like factors, and by secreted proteins of the ANGPTL family, which together determine the lipid composition and oxidation susceptibility of circulating lipoproteins [1,3,4]. For researchers, GO:0060587 provides a structured framework to interrogate how genetic and pharmacological perturbations alter lipoprotein oxidation. The term is experimentally tractable using CRISPR knockout, point-mutation, knock-in, and overexpression models in hepatocytes, macrophages, and endothelial cells, combined with mass spectrometry-based ox-LDL quantification and redox-sensitive reporters [6,8]. This article synthesizes the authoritative GO definition with verified PubMed literature to outline the mechanisms, key genes, disease links, and research methods relevant to regulation of lipoprotein lipid oxidation.

GO:0060587, regulation of lipoprotein lipid oxidation, is a biological process defined as any process that modulates the rate, frequency, or extent of lipoprotein lipid oxidation. Lipoprotein lipid oxidation itself is the modification of a lipoprotein by oxidation of the lipid group. In practical terms, this term covers the molecular and cellular events that either promote or suppress the oxidative modification of lipids carried within lipoprotein particles, such as low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very-low-density lipoprotein (VLDL).

Regulation of lipoprotein lipid oxidation is important because oxidized lipoproteins are causally implicated in atherosclerosis and cardiovascular disease, and the regulatory processes that control their formation are actionable therapeutic targets [7,8]. Nitric oxide and eNOS signaling directly modulate lipoprotein oxidation, linking endothelial health to lipoprotein quality [2,5]. Redox regulation in macrophages determines whether ox-LDL triggers foam cell formation, a hallmark of early atherosclerotic lesions. Consequently, genes and pathways that regulate this process are high-value targets for drug discovery and for CRISPR-based functional genomics [1,8].

The following genes and proteins have verified roles in lipid and lipoprotein metabolism, redox regulation, or oxidative stress pathways relevant to GO:0060587.

Regulation of lipoprotein lipid oxidation is controlled at multiple levels. Nitric oxide directly modulates free radical- and enzyme-mediated lipid and lipoprotein oxidation, and its production by eNOS is influenced by estradiol in cardiovascular pathology [2,5]. Redox regulation and lipid raft organization in macrophages govern the cellular response to ox-LDL and foam cell formation. Transcriptionally, PPAR activators regulate lipid and lipoprotein metabolism, while klf-3 controls lipoprotein assembly, secretion, and fatty acid beta-oxidation [3,4]. The ANGPTL3/4/8 axis provides endocrine and paracrine control over lipoprotein metabolism, indirectly shaping the lipid composition that determines oxidation susceptibility. Antioxidant pathways, including those reviewed in the context of atherosclerosis, counterbalance pro-oxidant forces and limit the extent of lipoprotein lipid oxidation [7,8].

Oxidized lipoproteins, particularly ox-LDL, are central to the initiation and progression of atherosclerosis [6,7]. Redox regulation and lipid rafts in macrophages mediate ox-LDL-induced foam cell formation, a hallmark of atherosclerotic plaques. Oxidative stress is a unifying mechanism in atherosclerosis, and antioxidants have been investigated as mechanistic interventions [7,8]. Regulation of lipoprotein lipid oxidation therefore directly influences cardiovascular disease risk and progression [2,7].

Endothelial nitric oxide synthase (eNOS) and estradiol-dependent signaling regulate HDL quality and lipoprotein oxidation, linking endothelial function to vascular pathology. Loss of NO bioavailability promotes oxidative modification of lipoproteins and endothelial dysfunction [2,5]. These mechanisms are relevant to hypertension, coronary artery disease, and other vascular disorders [5,7].

PPAR activators and ANGPTL proteins regulate lipid and lipoprotein metabolism, connecting lipoprotein oxidation to broader metabolic and inflammatory states [1,3]. Krüppel-like factor klf-3 controls lipoprotein assembly, secretion, and fatty acid beta-oxidation, processes that intersect with metabolic disease. Antioxidant status further modulates inflammatory signaling driven by oxidized lipoproteins.

Oxidized LDL and lipid peroxidation products can be quantified using mass spectrometry, ELISA, and thiobarbituric acid reactive substances (TBARS) assays [2,8]. These readouts directly measure the extent of lipoprotein lipid oxidation and are used to compare wild-type and genetically perturbed cells [6,8].

Redox-sensitive fluorescent probes and genetically encoded reporters enable real-time monitoring of oxidative stress in living cells [6,8]. Imaging of lipid rafts and oxidized lipoprotein uptake provides spatial information about where regulation occurs.

RNA sequencing and proteomics can identify transcriptional and protein-level changes in pathways regulating lipoprotein lipid oxidation [1,3,4]. These approaches are useful for discovering novel regulators and for validating CRISPR perturbations [1,8].

Pooled CRISPR knockout and activation screens in macrophages and endothelial cells can systematically identify genes that regulate ox-LDL uptake, foam cell formation, and lipid peroxidation [6,8]. Hits from these screens can be validated with targeted knockout or overexpression models.

Researchers studying regulation of lipoprotein lipid oxidation-related genes often need to determine whether a candidate gene is causally involved in oxidative modification of lipoproteins, and to dissect the precise molecular mechanism. EDITGENE provides end-to-end CRISPR services to generate the required knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support.

GO:0060587, regulation of lipoprotein lipid oxidation, captures a biologically and clinically important process that sits at the intersection of redox biology, lipid metabolism, and cardiovascular disease [2,7]. Nitric oxide, eNOS, PPARs, ANGPTLs, and antioxidant pathways collectively determine the extent to which lipoproteins undergo oxidative modification [1,2,3,5,8]. Because oxidized lipoproteins drive atherosclerosis and foam cell formation, genes regulating this process are attractive therapeutic and research targets [6,7]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with ox-LDL quantification and functional genomics, provide a rigorous framework for dissecting this regulation [1,6,8]. EDITGENE supports these efforts with tailored cell model generation, library screening, and bioinformatics services to accelerate discovery in lipoprotein oxidation research.